Option Care Health's revenue growth has decelerated sharply from 19.7% in 2024Q4 to 1.9% in 2026Q2, while gross margins have compressed from 20.8% to 18.5% over the same period, indicating structural reimbursement pressures.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 4, 2026 | $0.49+0.1% vs $0.49 | $1.5B+1.2% vs $1.5B |
Q3 2026 Jul 29, 2026 | $0.45+5.6% vs $0.43 | $1.4B+1.6% vs $1.4B |
Q2 2026 Apr 30, 2026 | $0.40+8.1% vs $0.37 | $1.4B-2.8% vs $1.4B |
Q1 2026 Feb 24, 2026 | $0.46+0.0% vs $0.46 | $1.5B+0.3% vs $1.5B |
Option Care (OPCH) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.45 per share a year ago.
BANNOCKBURN, Ill., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2026.
Option Care Health (NASDAQ: OPCH - Get Free Report) and InfuSystem (NYSE: INFU - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership. Profitability This table compares Option Care Health and
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Benchmark OPCH against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Option Care Health, Inc. (OPCH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $31.65 | $4.97B | 22.13 | 13.03% | 3.74% | 16.36% | — | |
| $36.36 | $1.26B | 36.88 | 36.31% | 3.05% | 9.04% | — | |
| $37.00 | $3.44B | -3.01 | 5.04% | -33.07% | -51.55% | — | |
| $24.28 | $1.67B | 16.06 | 7.08% | 5.58% | 20.22% | — | |
| $23.20 | $3.03B | -33.73 | 6.24% | -2.63% | -2.59% | — | |
| $8.97 | $1.22B | 136.74 | 15.93% | 0.88% | 3.25% | — |
Option Care Health, Inc. (OPCH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Option Care Health, Inc. (OPCH) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 29, 2026·SEC
May 22, 2026·SEC
May 12, 2026·SEC
Get notified when OPCH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Option Care Health, Inc. (OPCH) stock FAQ — growth, dividends, profitability & financials explained
Option Care Health, Inc. (OPCH) reported $5.75B in revenue over the trailing twelve months. Revenue was $5.65B in fiscal year 2025. That is 1895% more than the $283.2M of fiscal year 1996.
Option Care Health, Inc. (OPCH) grew revenue by 4.0% over the trailing twelve months, compared with the twelve months before.
Yes. Option Care Health, Inc. (OPCH) earned $215.2M in net income over the trailing twelve months (a 3.7% net margin).
Option Care Health, Inc. (OPCH) had a return on equity (ROE) of 16.4% over the trailing twelve months. That is above the market's typical 10-15%.
Option Care Health, Inc. (OPCH) generated $297.0M in free cash flow over the trailing twelve months.
